Showing results (341-350 of 413) with videos related to

Sort By:
Pageof 42
Cancer Letters|February 22, 2019
Tumor suppressor miR-215 counteracts hypoxia-induced colon cancer stem cell activityPit Ullmann, Martin Nurmik, Martine Schmitz, et al.
Dalton Transactions (Cambridge, England : 2003)|September 17, 2019
Highly soluble fluorine containing Cu(i) AlkylPyrPhos TADF complexesJasmin M Busch, Daniel M Zink, Patrick Di Martino-Fumo, et al.
The Journal of Rheumatology|June 3, 2009
Facilitating the use of COBRA combination therapy in early rheumatoid arthritis: a pilot implementation studyLilian H D van Tuyl, Anne Marie C Plass, Willem F Lems, et al.
Australian Journal of Primary Health|August 13, 2021
Perspectives of Australian GPs on tailoring fall risk management: a qualitative studyLynette Mackenzie, Jeannine Liddle, Lindy M Clemson, et al.
Annals of the Rheumatic Diseases|April 23, 2013
A non-inferiority trial of an attenuated combination strategy ('COBRA-light') compared to the original COBRA strategy: clinical results after 26 weeksDebby den Uyl, Marieke ter Wee, Maarten Boers, et al.
Diseases (Basel, Switzerland)|July 25, 2025
Subcutaneous Panniculitis-like T-Cell Lymphoma: Diagnostic Challenge and Successful Multimodal Management with Integra® Dermal Matrix-Case Report and Review of the LiteratureDaniel Pit, Teodora Hoinoiu, Bogdan Hoinoiu, et al.
Cancers|January 11, 2022
Effects of Red Blood Cell Transfusions on Distant Metastases of Oral Squamous Cell CarcinomasLeonard Simon Brandenburg, Marc Christian Metzger, Philipp Poxleitner, et al.
Current Oncology (Toronto, Ont.)|May 26, 2023
Pregnancy in a Young Patient with Metastatic HER2-Positive Breast Cancer-Between Fear of Recurrence and Desire to ProcreateCristina Marinela Oprean, Andrei Dorin Ciocoiu, Nusa Alina Segarceanu, et al.
Inorganic Chemistry|July 25, 2022
Unexpected Boost in Activity of a Cu(I) Photosensitizer by Stabilizing a Transient Excited StateMartin Rentschler, Pit Jean Boden, Miguel A Argüello Cordero, et al.
Rheumatology (Oxford, England)|February 23, 2018
TNF inhibitor treatment is associated with a lower risk of hand osteoarthritis progression in rheumatoid arthritis patients after 10 yearsMarieke Loef, Féline P B Kroon, Sytske Anne Bergstra, et al.
Pageof 42